Dr Dipika Bansal

Employment

• National Institute of Pharmaceutical Education and Research Professor & Head
  2024 - Present
• National Institute of Pharmaceutical Education and Research Associate Professor
  2016 - 2024
• National Institute of Pharmaceutical Education and Research Assistant Professor
  2010 - 2016
• PGIMER Senior research associate
  2010 - 2010

Education

• Government Medical College and Hospital MBBS
  1998 - 2002

Projects & Funding

Projects & funding information is unavailable.

Publications (101)

• A model‐based cost‐effectiveness estimates of hormonal therapy in Indian children with infantile epileptic spasms syndrome
  Epilepsia Open 2025 DOI: 10.1002/epi4.70106
  +Save
• Efficacy of stem cell therapy for avascular necrosis of the femoral head: A systematic review and Meta-analysis
  Bone 2025 DOI: 10.1016/j.bone.2025.117590
  +Save
• Safety Profile of Istradefylline in Parkinson’s Disease: A Meta-Analysis of Randomized Controlled Trials and Disproportionality Analysis Using FAERS
  Journal of Geriatric Psychiatry and Neurology 2025 DOI: 10.1177/08919887251343608
  +Save
• Insights into the systemic risk factors associated with diabetic retinopathy in the Indian population: A comprehensive systematic review and meta-analysis
  Indian Journal of Ophthalmology 2025 DOI: 10.4103/IJO.IJO_818_24
  +Save
• Efficacy and safety of dietary therapies in drug-resistant pediatric epilepsy: a synopsis of the available evidence
  Journal of the International Child Neurology Association 2024
  +Save
• Comprehensive safety evaluation of isatuximab in multiple myeloma using disproportionality analysis of FAERS and meta-analysis of randomized controlled trials
  Scientific Reports 2024 DOI: 10.1038/s41598-024-83014-1
  +Save
• Update on Cannabidiol in Drug-Resistant Epilepsy
  Indian Journal of Pediatrics 2024 DOI: 10.1007/s12098-024-05337-1
  +Save
• First-choice hormonal therapies for children with infantile epileptic spasms syndrome in South Asia: A network meta-analysis of randomized controlled trials
  Epilepsia Open 2024 DOI: 10.1002/epi4.13086
  +Save
• Mitigating treatment lag for infantile epileptic spasms syndrome in low- and middle-income countries: Key recommendations from the South Asia allied IESS Research Group
  Epilepsia 2024 DOI: 10.1111/epi.18090
  +Save
• Comparative efficacy and safety of alpha-blockers as monotherapy for benign prostatic hyperplasia: a systematic review and network meta-analysis
  Scientific Reports 2024 DOI: 10.1038/s41598-024-61977-5
  +Save